Insider Selling News: Intercept Pharmaceuticals Inc (ICPT), Kite Pharma Inc (KITE), Agios Pharmaceuticals Inc (AGIO), Pacira Pharmaceuticals Inc (PCRX)


Recently, various executives have taken part in insider selling activity for the stocks of Intercept Pharmaceuticals Inc (NASDAQ:ICPT), Kite Pharma Inc (NASDAQ:KITE), Agios Pharmaceuticals Inc (NASDAQ:AGIO), and Pacira Pharmaceuticals Inc (NASDAQ:PCRX).

Intercept Pharmaceuticals Inc

CMO David Shapiro unloaded 4,272 Intercept Pharmaceuticals shares (18.98% of total stake), valued at $894,429, in a transaction dated August 17. The shares were sold via automatic sale program. Shapiro now holds 18,233 of the company’s shares that are valued at $3,766,573.

Click Here to see the performance of Intercept Pharmaceuticals insiders.

Kite Pharma Inc

VP of Clinical Development Jeffrey Wiezorek sold 9,000 Kite Pharma shares, valued at $547,820, in three transactions dated August 17. The shares were sold via automatic sale program. Wiezorek now holds 5,218 of the company’s shares that are valued at $317,614.

VP of Regulatory Affairs Rizwana Sproule unloaded 9,567 shares, valued at $582,407, on August 17.  The shares were sold via automatic sale program. Sproule now holds 1,695 of the company’s shares that are valued at $103,186.

Chief Scientific Officer Margo Roberts disposed of 6,145 shares, valued at $374,236. The shares were sold via automatic sale program. Roberts now holds 999 of the company’s shares that are valued at $60,840.

Click Here to see the performance of Kite Pharma insiders.

Agios Pharmaceuticals Inc

Chief Operating Officer John Duncan Higgons unloaded 20,000 Agios Pharmaceuticals shares (13.17% of total stake), valued at $1,844,800, in a transaction dated August 17. The shares were sold via automatic sale program. Higgons now holds 131,835 of the company’s shares that are valued at $12,171,007.

According to TipRanks.com, which measures corporate insiders’ success based on their transactions, John Duncan Higgons has an average return of 76.2% and a 60% success rate. Higgons is ranked #957 out of 33584 corporate insiders.

Director Lewis Clayton Cantley on August 18 unloaded 9,704 shares (3.08% of total stake), valued at $921,322, in multiple transactions date August 17-18. The shares were sold via automatic sale program. Cantley now holds 152,706 of the company’s shares that are valued at $14,097,818.

Click Here to see the performance of Agios Pharmaceuticals insiders.

Pacira Pharmaceuticals Inc

Director Paul Hastings disposed of 3,000 Pacira shares (51.26% of total stake), valued at $180,060, in a transaction dated August 17. The shares were sold via automatic sale program. Hastings now holds 2,853 of the company’s shares that are valued at $181,422.

Click Here to see the performance of Pacira Pharmaceuticals insiders.